Despite the many basic research discoveries in genetics, relatively few gene-based treatments, drugs, or preventative measures have been developed. One way to bridge this gap may be for industry, academia, and government to develop partnerships that share resources while distributing risk. However, intellectual property protections and other barriers can inhibit collaborative efforts. The Institute of Medicine held a workshop on July 22, 2010, to explore these issues and develop solutions.–Publisher’s description.
Medicine
{PDF} Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Drug Development: Workshop Summary Roundtable on Translating Genomic-Based Research on Health, Institute of Medicine
$9.99


![[PDF] Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office Committee on the Review of Priorities in the National Vaccine Plan, Institute of Medicine](https://digzon.com/wp-content/uploads/2024/04/1f2c64632df721369b594e97e25221d1-d-247x296.jpg)

![[PDF] 2008 Amendments to the National Academies' Guidelines for Human Embryonic Stem Cell Research Human Embryonic Stem Cell Research Advisory Committee, National Research Council, Institute of Medicine, National Academies](https://digzon.com/wp-content/uploads/2024/04/266bcf8509c7558de3673f1cd4917916-d-247x296.jpg)
![[PDF] On Being a Scientist: Responsible Conduct in Research, Second Edition National Academy of Sciences, National Academy of Engineering, Institute of Medicine](https://digzon.com/wp-content/uploads/2024/04/8a3bc970ab750124f6706d0bea8cc1ff-d-247x296.jpg)
Reviews
There are no reviews yet.